Schizophrenia and the neurodevelopmental continuum:evidence from genomics

World Psychiatry

Volumn 16, Issue 3, 2017, Pages 227-235

  Owen, Michael J ^a   O'Donovan, Michael C ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

ADHD; autism; bipolar disorder; copy number variants; genomics; intellectual disability; neurodevelopment; Schizophrenia

Indexed keywords

ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; BIPOLAR DISORDER; COGNITION; COPY NUMBER VARIATION; EVIDENCE BASED PRACTICE; GENETIC ANALYSIS; GENETIC RISK; GENETIC VARIABILITY; GENOMICS; HUMAN; INTELLECTUAL IMPAIRMENT; MENTAL DISEASE; NERVE CELL DIFFERENTIATION; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 85029721725     PISSN: 17238617     EISSN: 20515545     Source Type: Journal    
DOI: 10.1002/wps.20440     Document Type: Article

References (78)

1. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987;44:660-9.
2. Murray RM, Lewis SW. Is schizophrenia a neurodevelopmental disorder? BMJ (Clin Res Ed) 1988;296:63.
3. Weinberger DR, Levitt P. Neurodevelopmental origins of schizophrenia. In: Weinberger DR, Harrison PJ (eds). Schizophrenia, 3rd ed. Oxford: Wiley-Blackwell, 2011:393-412.
4. Owen MJ, O'Donovan MC, Thapar A et al. Neurodevelopmental hypothesis of schizophrenia. Br J Psychiatry 2011;198:173-5.
5. Rutter M, Moffitt TE, Caspi A. Gene-environment interplay and psychopathology: multiple varieties but real effects. J Child Psychol Psychiatry 2006;47:226-61.
6. Craddock N, Owen MJ. The Kraepelinian dichotomy - Going, going… but still not gone. Br J Psychiatry 2010;196:92-5.
7. Doherty JL, Owen MJ. Genomic insights into the overlap between psychiatric disorders: implications for research and clinical practice. Genome Med 2014;6:29.
8. Owen MJ. New approaches to psychiatric diagnostic classification. Neuron 2014;84:564-71.
9. Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet 2016;388:86-97.
10. Lilienfeld AM, Pasamanick B, Rogers M. Relationship between pregnancy experience and the development of certain neuropsychiatric disorders in childhood. Am J Publ Health Nations Health 1955;45:637-43.
11. Capute AJ, Palmer FB. A pediatric overview of the spectrum of developmental disabilities. J Dev Behav Pediatr 1980;1:66-9.
12. Moreno-De-Luca A, Myers SM, Challman TD et al. Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence. Lancet Neurol 2013;12:406-14.
13. Lichtenstein P, Yip BH, Björk C et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009;373:234-9.
14. Sullivan PF, Magnusson C, Reichenberg A et al. Family history of schizophrenia and bipolar disorder as risk factors for autism. Arch Gen Psychiatry 2012;69:1099-103.
15. Sanchez-Gistau V, Romero S, Moreno D et al. Psychiatric disorders in child and adolescent offspring of patients with schizophrenia and bipolar disorder: a controlled study. Schizophr Res 2015;168:197-203.
16. Chou I-J, Kuo C-F, Huang Y-S et al. Familial aggregation and heritability of schizophrenia and co-aggregation of psychiatric illnesses in affected families. Schizophr Bull 2016;460:744-7.
17. Thapar A, Cooper M, Eyre O et al. Practitioner review: what have we learnt about the causes of ADHD? J Child Psychol Psychiatry Allied Discip 2013;54:3-16.
18. Mandy W, Lai M-C. Annual research review: the role of the environment in the developmental psychopathology of autism spectrum condition. J Child Psychol Psychiatry 2016;57:271-92.
19. Nosarti C, Reichenberg A, Murray RM et al. Preterm birth and psychiatric disorders in young adult life. Arch Gen Psychiatry 2012;69:610-7.
20. Abel KM, Wicks S, Susser ES et al. Birth weight, schizophrenia, and adult mental disorder: is risk confined to the smallest babies? Arch Gen Psychiatry 2010;67:923-30.
21. Mathewson KJ, Chow CHT, Dobson K et al. Mental health of extremely low birth weight survivors: a systematic review and meta-analysis. Psychol Bull 2017;143:347-83.
22. Sullivan PF, Daly MJ, O'Donovan M. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet 2012;13:537-51.
23. Ripke S, Neale BM, Corvin A et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014;511:421-7.
24. Purcell SM, Wray NR, Stone JL et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009;10:8192-2.
25. Ripke S, O'Dushlaine C, Chambert K et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 2013;45:1150-9.
26. Loh P-R, Bhatia G, Gusev A et al. Contrasting genetic architectures of schizophrenia and other complex diseases using fast variance-components analysis. Nat Genet 2015;47:1385-92.
27. Malhotra D, Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell 2012;148:1223-41.
28. Rees E, Walters JTR, Georgieva L et al. Analysis of copy number variations at 15 schizophrenia-associated loci. Br J Psychiatry 2014;204:108-14.
29. Rees E, Walters JTR, Chambert KD et al. CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1. Hum Mol Genet 2014;23:1669-76.
30. Marshall CR, Howrigan DP, Merico D et al. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nat Genet 2016;49:27-35.
31. Kirov G, Gumus D, Chen W et al. Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum Mol Genet 2008;17:458-65.
32. Walsh T, McClellan JM, McCarthy SE et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008;320:539-43.
33. Glessner JT, Reilly MP, Kim CE et al. Strong synaptic transmission impact by copy number variations in schizophrenia. Proc Natl Acad Sci USA 2010;107:10584-9.
34. Kirov G, Pocklington AJ, Holmans P et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry 2012;17:142-53.
35. Szatkiewicz JP, O'Dushlaine C, Chen G et al. Copy number variation in schizophrenia in Sweden. Mol Psychiatry 2014;19:762-73.
36. Pocklington AJ, Rees E, Walters JTR et al. Novel findings from CNVs implicate inhibitory and excitatory signaling complexes in schizophrenia. Neuron 2015;86:1203-14.
37. Fromer M, Pocklington AJ, Kavanagh DH et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 2014;506:179-84.
38. Purcell SM, Moran JL, Fromer M et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 2014;506:185-90.
39. Genovese G, Fromer M, Stahl EA et al. Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia. Nat Neurosci 2016;19:1433-41.
40. Singh T, Kurki MI, Curtis D et al. Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders. Nat Neurosci 2016;19:571-7.
41. O'Dushlaine C, Rossin L, Lee PH et al. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat Neurosci 2015;18:199-209.
42. Sebat J, Levy DL, McCarthy SE. Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. Trends Genet 2009;25:528-35.
43. Williams NM, Zaharieva I, Martin A et al. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 2010;376:1401-8.
44. Stefansson H, Meyer-Lindenberg A, Steinberg S et al. CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature 2013;505:361-6.
45. Kendall KM, Rees E, Escott-Price V et al. Cognitive performance among carriers of pathogenic copy number variants: analysis of 152,000 UK biobank subjects. Biol Psychiatry 2017;82:103-10.
46. Kirov G, Rees E, Walters JTR et al. The penetrance of copy number variations for schizophrenia and developmental delay. Biol Psychiatry 2014;75:378-85.
47. O'Donovan MC, Owen MJ. The implications of the shared genetics of psychiatric disorders. Nat Med 2016;22:1214-9.
48. Girirajan S, Brkanac Z, Coe BP et al. Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genet 2011;7:e1002334.
49. Rees E, Kendall K, Pardiñas AF et al. Analysis of intellectual disability copy number variants for association with schizophrenia. JAMA Psychiatry 2016;73:963-9.
50. Craddock N, Sklar P. Genetics of bipolar disorder. Lancet 2013;381:1654-62.
51. Grozeva D. Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia. Arch Gen Psychiatry 2010;67:318-27.
52. Bergen SE, O'Dushlaine CT, Ripke S et al. Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Mol Psychiatry 2012;17:880-6.
53. Green EK, Rees E, Walters JTR et al. Copy number variation in bipolar disorder. Mol Psychiatry 2016;21:89-93.
54. Grozeva D, Kirov G, Conrad DF et al. Reduced burden of very large and rare CNVs in bipolar affective disorder. Bipolar Disord 2013;15:893-8.
55. Priebe L, Degenhardt FA, Herms S et al. Genome-wide survey implicates the influence of copy number variants (CNVs) in the development of early-onset bipolar disorder. Mol Psychiatry 2012;17:421-32.
56. Malhotra D, McCarthy S, Michaelson JJ et al. High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron 2011;72:951-63.
57. Power RA, Kyaga S, Uher R et al. Fecundity of patients with schizophrenia, autism, bipolar disorder, depression, anorexia nervosa, or substance abuse vs their unaffected siblings. JAMA Psychiatry 2013;70:22-30.
58. Georgieva L, Rees E, Moran JL et al. De novo CNVs in bipolar affective disorder and schizophrenia. Hum Mol Genet 2014;23:6677-83.
59. Sanders SJ, He X, Willsey AJ et al. Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci. Neuron 2015;87:1215-33.
60. Vulto-van Silfhout AT, Hehir-Kwa JY, van Bon BWM et al. Clinical significance of de novo and inherited copy-number variation. Hum Mutat 2013;34:1679-87.
61. McRae JF, Clayton S, Fitzgerald TW et al. Prevalence and architecture of de novo mutations in developmental disorders. Nature 2017;542:433-8.
62. Singh T, Walters JTR, Johnstone M et al. Rare schizophrenia risk variants are enriched in genes shared with neurodevelopmental disorders. bioRxiv 2016:69344.
63. Robinson EB, St Pourcain B, Anttila V et al. Genetic risk for autism spectrum disorders and neuropsychiatric variation in the general population. Nat Genet 2016;48:552-5.
64. Rauch A, Wieczorek D, Graf E et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet 2012;380:1674-82.
65. De Rubeis S, He X, Goldberg AP et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 2014;515:209-15.
66. Kataoka M, Matoba N, Sawada T et al. Exome sequencing for bipolar disorder points to roles of de novo loss-of-function and protein-altering mutations. Mol Psychiatry 2016;21:885-93.
67. Goes FS, Pirooznia M, Parla JS et al. Exome sequencing of familial bipolar disorder. JAMA Psychiatry 2016;73:590-7.
68. Anttila V, Bulik-Sullivan B, Finucane HK et al. Analysis of shared heritability in common disorders of the brain. bioRxiv 2016:48991.
69. O'Donovan MC. What have we learned from the Psychiatric Genomics Consortium. World Psychiatry 2015;14:291-3.
70. Pardiñas AF, Holmans P, Pocklington AJ et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and maintained by background selection. bioRxiv 2016:68593.
71. Tansey KE, Rees E, Linden DE et al. Common alleles contribute to schizophrenia in CNV carriers. Mol Psychiatry 2016;21:1085-9.
72. Hubbard L, Tansey KE, Rai D et al. Evidence of common genetic overlap between schizophrenia and cognition. Schizophr Bull 2016;42:832-42.
73. Riglin L, Collishaw S, Richards A et al. Schizophrenia risk alleles and neurodevelopmental outcomes in childhood: a population-based cohort study. Lancet Psychiatry 2017;4:57-62.
74. St Pourcain B, Robinson EB, Anttila V et al. ASD and schizophrenia show distinct developmental profiles in common genetic overlap with population-based social communication difficulties. Mol Psychiatry (in press).
75. D'Angelo D, Lebon S, Chen Q et al. Defining the effect of the 16p11.2 duplication on cognition, behavior, and medical comorbidities. JAMA Psychiatry 2016;73:20-30.
76. Owen MJ, Doherty JL. What can we learn from the high rates of schizophrenia in people with 22q11.2 deletion syndrome? World Psychiatry 2016;15:23-5.
77. Rees E, Kirov G, Sanders A et al. Evidence that duplications of 22q11.2 protect against schizophrenia. Mol Psychiatry 2014;19:37-40.
78. McCarroll SA, Hyman SE, Han Y et al. Progress in the genetics of polygenic brain disorders: significant new challenges for neurobiology. Neuron 2013;80:578-87.